VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,612 | -30.2% | 15,296 | -21.9% | 0.05% | -24.2% |
| Q2 2023 | $589,526 | -85.5% | 19,579 | -84.4% | 0.07% | -85.6% |
| Q1 2023 | $4,056,492 | -16.6% | 125,394 | -26.1% | 0.46% | -16.3% |
| Q4 2022 | $4,862,304 | -99.9% | 169,655 | -3.2% | 0.55% | +12.3% |
| Q3 2022 | $4,228,577,000 | +5.0% | 175,314 | +19.2% | 0.49% | +13.3% |
| Q2 2022 | $4,026,976,000 | +60657.0% | 147,077 | -14.9% | 0.43% | -27.6% |
| Q1 2022 | $6,628,000 | +171.1% | 172,819 | +126.4% | 0.59% | +231.8% |
| Q4 2021 | $2,445,000 | -18.4% | 76,319 | -24.9% | 0.18% | -21.8% |
| Q3 2021 | $2,995,000 | +108.0% | 101,625 | +139.9% | 0.23% | +114.0% |
| Q2 2021 | $1,440,000 | +184.0% | 42,370 | +171.5% | 0.11% | +174.4% |
| Q1 2021 | $507,000 | – | 15,607 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |